Isocaloric Diet ( DrugBank: - )

2 diseases

ID	Disease name (Link within this page)	Number of trials
2	Amyotrophic lateral sclerosis	1
83	Addison disease	1

2. Amyotrophic lateral sclerosis

Clinical trials : 624 / Drugs : 611 - (DrugBank : 160) / Drug target genes : 172 - Drug target pathways : 225

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04654689 (ClinicalTrials.gov)	November 20, 2021	13/11/2020	Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients	Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients	Amyotrophic Lateral Sclerosis	Dietary Supplement: Liposomed polyphenols resveratrol and curcumin;Other: Placebo for liposomed resveratrol and curcumin;Dietary Supplement: Isocaloric Diet;Drug: G04CB02;Other: Placebo microcrystalline methylcellulose	Fundación Universidad Católica de Valencia San Vicente Mártir	NULL	Recruiting	18 Years	75 Years	All	60	Phase 2	Spain

Clinical trials : 20 / Drugs : 43 - (DrugBank : 13) / Drug target genes : 6 - Drug target pathways : 18

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00688987 (ClinicalTrials.gov)	August 2000	30/5/2008	The Hypothalamic-Pituitary-Adrenal (HPA) Axis as an Effector System in Weight Regulation	Cortisol, Central Obesity, and Insulin Resistance: Long Term Studies in Addison's Patients	Obesity;Addison's Disease	Drug: Hydrocortisone;Dietary Supplement: Isocaloric Diet	Oregon Health and Science University	NULL	Completed	18 Years	N/A	Both	24	N/A	United States